The growth-promoting effect of human whole blood serum on cultured human aortic smooth muscle cells is a constant serum donor-dependent property
- 18 Downloads
Summary
We studied the variation in the mitogenicity of the sera derived from any particular subject at different time points. Two sets of sera were taken at an interval of 3 wk from 12 healthy male conscripts, and the samples were tested with regard to their ability to support proliferation of cultured human aortic smooth muscle cells (HSMC). Sera from 12 individual showed markedly different growth-stimulating effects. On the other hand, sera from any particular individual taken at different time points gave constantly the same result. This was evident when the sera from the two time points were tested fresh in separate experiments and when they were tested together in one experiment after storage of 4 to 5 mo. The growth-promoting effects of the sera did not correlate significantly with the concentration of certain measurable serum factors which are known to be mitogenic for arterial smooth muscle cells (low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, growth hormone, insulin, or insulike growth factor-I). Our results indicate that the growth-promoting effect of human serum on cultured HSMC is a constant serum donor-dependent property. This implies that it is possible to make reliable comparisons between the growth-promoting effects of the sera derived from different subjects, and to measure the effects of treatments, e. g. medical or dietary, on the mitogenicity of the sera from any given individual.
Key words
cell proliferation human aortic smooth muscle cells human whole blood serumPreview
Unable to display preview. Download preview PDF.
References
- 1.Augustyn, J. M.; Fritz, K. E.; Daoud, A. S., et al. Effect of lipoprotein on in vitro synthesis of DNA in aortic tissue. Atherosclerosis 27:179–188; 1977.CrossRefGoogle Scholar
- 2.Berk, B. C.; Brock, T. A.; Webb, R. C., et al. Epidermal growth factor, a vascular smooth muscle mitogen, induces rat aortic contraction. J. Clin. Invest. 75:1083–1086; 1985.PubMedCrossRefGoogle Scholar
- 3.Buchwald, M. Use of cultured cells for biochemical analysis. Clin. Biochem. 17:143–150; 1984.PubMedCrossRefGoogle Scholar
- 4.Chen, T. R. In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. Exp. Cell. Res. 104:255–262; 1977.PubMedCrossRefGoogle Scholar
- 5.Fischer-Dzoga, K.; Wissler, R. W. Stimulation in stationary primary cultures of monkey aortic smooth muscle cells. Part 2. Effects of varying concentrations of hyperlipemic serum and lipoproteins of varying fat origins. Atherosclerosis 24:515–525; 1976.PubMedCrossRefGoogle Scholar
- 6.Friedewald, W. T.; Levy, R. I.; Fredrickson, D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18:499–502; 1972.PubMedGoogle Scholar
- 7.Gospodarowicz, D.; Hirabayashi, K.; Giguere, L., et al. Factors controlling the proliferative rate, final cell density, and life span of bovine vascular smooth muscle cells in culture. J. Cell. Biol. 89:568–578; 1981.PubMedCrossRefGoogle Scholar
- 8.Hamet, P.; Sugimoto, H.; Umeda, F., et al. Platelets and vascular smooth muscle: Abnormalities of phosphodiesterase, aggregation and cell growth in experimental and human diabetes. Metabolism 32 (suppl. 1):124–130; 1983.PubMedCrossRefGoogle Scholar
- 9.Jalkanen, M.; Larjava, H.; Turakainen, H., et al. Improved application of the diphenylamine reaction for the determination of DNA. J. Biochem. Biophys. Meth. 3:195–199; 1980.PubMedCrossRefGoogle Scholar
- 10.Järveläinen, H.; Halme, T.; Lehtonen, A., et al. Serum from type IIA hyperlipoproteinemic patients does not stimulate proliferation of and collagen synthesis in human fetal aortic smooth muscle cells in culture. Atherosclerosis 56:199–211; 1985.PubMedCrossRefGoogle Scholar
- 11.Koschinsky, T.; Bunting, C. E.; Schwippert, B., et al. Studies on inherited and acquired metabolic disorders in cultured arterial smooth muscle cells and fibroblasts. Int. J. Obsity 1 (suppl. 6):91–104; 1982.Google Scholar
- 12.Ledet, T. Growth hormone stimulating the growth of arterial medial cells in vitro. Absence of effect of insulin. Diabetes 25:1011–1017; 1976.PubMedCrossRefGoogle Scholar
- 13.Nilsson, J.; Ksiazek, T.; Heldin, C-H, et al. Demonstration of stimulatory effects of platelet-derived growth factor on cultivated rat arterial smooth muscle cells. Exp. Cell Res. 147:231–237; 1983.CrossRefGoogle Scholar
- 14.Olashaw, N.; Harrington, M.; Pledger, W. J. The regulation of the cell cycle by multiple growth factors. Cell Biol. Int Rep. 7:489–491; 1983.CrossRefGoogle Scholar
- 15.Pfeifle, B.; Ditschuneit, H. The effect of insulin and insulin-like growth factors on cell proliferation of human smooth muscle cells. Artery 8:336–341; 1980.PubMedGoogle Scholar
- 16.Pfeifle, B.; Ditschuneit, H. Effect of insulin on growth of cultured human arterial smooth muscle cells. Diabetologia 20:155–158; 1981.PubMedCrossRefGoogle Scholar
- 17.Pledger, W. J.; Stiles, C. D.; Antoniades, H. N., et al. Induction of DNA synthesis in BALB/c 3T3 cells by serum components: Reevaluation of the commitment process. Proc. Natl. Acad. Sci. USA 74:4481–4485; 1977.PubMedCrossRefGoogle Scholar
- 18.Ross, R.; Glomset, J.; Kariya, B., et al. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc. Natl. Acad. USA 71:1207–1210; 1974.CrossRefGoogle Scholar
- 19.Ross, R.; Glomset, J.; Kariya, B., et al. Role of platelet factors in the growth of cells in culture. Natl. Cancer Inst. Monogr. 48:103–108; 1978.PubMedGoogle Scholar
- 20.Rønning, Ø. W.; Pettersen, E. O. Effect of different growth factors on cell cycle traverse and protein growth of human cells in culture. Exp. Cell Res. 157:29–40; 1985.PubMedCrossRefGoogle Scholar
- 21.Rönnemaa, T.; Doherty, N. S. Effect of serum and liver extracts from hypercholesterolemic rats on the synthesis of collagen by isolated aortas and cultured smooth muscle cells. Atherosclerosis 26:261–272; 1977.PubMedCrossRefGoogle Scholar
- 22.Schwartz, S. M.; Gajdusek, C. M. Growth factors and the vessel wall. Prog. Hemost. Thromb. 6:85–112; 1982.PubMedGoogle Scholar
- 23.Stiles, C. D.; Capone, G. T.; Scher, C. D., et al. Dual control of cell growth by somatomedins and platelet-derived growth factor. Proc. Natl. Acad. Sci. USA 76:1279–1283; 1979.PubMedCrossRefGoogle Scholar
- 24.Talha, S.; Harel, E. Early stimulation of ATP turnover induced by growth factors. Synergitic effect of EGF and insulin and correlation with DNA synthesis. Exp. Cell Res. 158:311–320; 1985.PubMedCrossRefGoogle Scholar
- 25.Viikari, J. Precipitation of plasma lipoproteins by PEG-6000 and its evaluation with electrophoresis and ultracentrifugation. Scand. J. Clin. Lab. Invest. 36:265–268; 1976.Google Scholar
- 26.Williams, L. T.; Tremble, P.; Antoniades, H. N. Platelet-derived growth factor binds specifically to receptors on vascular smooth muscle cells and the binding becomes nondissosiable. Proc. Natl. Acad. Sci. USA 79:5867–5870; 1982.PubMedCrossRefGoogle Scholar